VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 175 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,383 | -56.1% | 361 | -9.8% | 0.00% | – |
| Q2 2023 | $7,710 | +175.0% | 400 | +100.0% | 0.00% | – |
| Q1 2023 | $2,804 | +70000.0% | 200 | -10.3% | 0.00% | – |
| Q4 2022 | $4 | -99.9% | 223 | +11.5% | 0.00% | – |
| Q3 2022 | $3,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q2 2022 | $3,000 | -50.0% | 200 | -50.0% | 0.00% | – |
| Q1 2022 | $6,000 | -25.0% | 400 | +100.0% | 0.00% | – |
| Q4 2021 | $8,000 | -11.1% | 200 | 0.0% | 0.00% | – |
| Q3 2021 | $9,000 | -66.7% | 200 | -66.2% | 0.00% | -100.0% |
| Q2 2021 | $27,000 | -18.2% | 591 | -11.3% | 0.00% | 0.0% |
| Q1 2021 | $33,000 | +120.0% | 666 | +9.9% | 0.00% | 0.0% |
| Q4 2020 | $15,000 | -6.2% | 606 | +28.7% | 0.00% | 0.0% |
| Q3 2020 | $16,000 | +128.6% | 471 | +135.5% | 0.00% | 0.0% |
| Q2 2020 | $7,000 | +16.7% | 200 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $6,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $36,281,234 | 32.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 18,319,938 | $426,304,957 | 3.50% |
| Zebra Capital Management LLC | 27,110 | $631 | 3.15% |
| Avidity Partners Management LP | 1,640,200 | $38,167,454 | 1.27% |
| Sofinnova Investments, Inc. | 657,559 | $15,301,398 | 0.98% |
| DCF Advisers, LLC | 62,000 | $1,442,740 | 0.88% |
| SECTOR GAMMA AS | 145,545 | $3,386,832 | 0.82% |
| Temasek Holdings (Private) Ltd | 5,814,972 | $135,314,398 | 0.80% |
| BRAIDWELL LP | 604,036 | $14,055,918 | 0.46% |
| SummerHaven Investment Management, LLC | 26,045 | $606,067 | 0.35% |